...
机译:与雌激素受体阳性乳腺癌抗原对芳香酶抑制剂(AIS)的抗性的发展相关的生物标志物改变
Breast Cancer Unit Department of Medical Oncology Institut Gustave Roussy Villejuif France;
NE Thames Regional Genetics Laboratory Great Ormond Street Hospital London United Kingdom;
Academic Department of Biochemistry Royal Marsden Hospital London United Kingdom;
Clinical Trials and Statistics Unit The Institute of Cancer Research London United Kingdom;
Academic Department of Biochemistry Royal Marsden Hospital London United Kingdom;
Breast Cancer Unit Department of Medical Oncology Institut Gustave Roussy Villejuif France;
Clinical Trials and Statistics Unit The Institute of Cancer Research London United Kingdom;
Memorial Sloan-Kettering Cancer Centre New York United States;
Breast Cancer Unit Department of Medical Oncology Institut Gustave Roussy Villejuif France NE;
Aromatase inhibitor; Breast cancer; Immunohistochemistry; Relapse;
机译:与雌激素受体阳性乳腺癌抗原对芳香酶抑制剂(AIS)的抗性的发展相关的生物标志物改变
机译:用芳香糖酶抑制剂(AI's)和选择性雌激素改性剂预处理促血管蛋白酶阳性转移性乳腺癌前代妇女血尿血症血尿症的回顾性研究
机译:紫杉酶抑制剂敏感和芳香酶抑制剂抗性雌激素受体阳性乳腺癌抗肿瘤活性
机译:雌激素受体阳性乳腺癌:传统预测,分子病理:新的乳腺癌分类和21世纪个性化预测和预测测定
机译:合成的齐墩果烷三萜类化合物和组蛋白脱乙酰基酶抑制剂伏立诺他合用以延迟雌激素受体-阴性乳腺癌转基因模型中的肿瘤发展。
机译:与雌激素受体阳性乳腺癌抵抗芳香化酶抑制剂(AIs)的发展相关的生物标志物变化
机译:雌激素受体阳性乳腺癌患者的响应和抗PI3K抑制剂的生物标志物及涉及PI3K抑制剂的组合疗法
机译:膳食染料木黄酮,雌马酚和芳香酶抑制剂对无胸腺小鼠雌激素依赖性人乳腺癌(mCF-7Ca)细胞生长的影响